الولايات المتحدة · وكالات وأخبار لحظية · PR Newswire

Breakthrough T1D Funded Clinical Trial Testing Islet Cell Transplantation with Eledon's Tegoprubart Expands to Include People with Type 1 Diabetes and Kidney Disease

نشره PR Newswire · الولايات المتحدة منذ 2 س

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon…

اقرأ المقال كاملًا على PR Newswire سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.prnewswire.com)

يستحق القراءة أيضًا

Associated Press (Business)

Why Rubio is visiting a small Indian city that’s home to world’s largest oil-refining complex

Business Wire

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Dow Jones Newswires

Breakthrough T1D Funded Clinical Trial Testing Islet Cell Transplantation with Eledon's Tegoprubart Expands to Include People with Type 1 Diabetes and Kidney Disease

مشاركة

يستحق القراءة أيضًا

Why Rubio is visiting a small Indian city that’s home to world’s largest oil-refining complex

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening